ICVX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 119194 min ago

@ $15.42

Wydano: 13 vas. 2024 @ 22:51

Zwrot: -0.71%

Poprzedni sygnał: vas. 13 - 20:32

Poprzedni sygnał: Sprzedaż

Zwrot: -0.39 %

Live Chart Being Loaded With Signals

Commentary (16 vas. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	8.56M
Średni wolumen	1.05M
Kapitalizacja rynkowa	769.04M
EPS	$0 ( 2024-04-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.96
ATR14	$0.208 (1.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-19	Ra Capital Management, L.p.	Sell	638 668	Common Stock
2024-02-19	Ra Capital Management, L.p.	Sell	22 278	Stock Option (Right to Buy)
2024-02-19	Ra Capital Management, L.p.	Sell	17 000	Stock Option (Right to Buy)
2024-02-19	Simpson Adam K.	Sell	129 032	Common Stock
2024-02-19	Simpson Adam K.	Sell	191 449	Stock Option (Right to Buy)

INSIDER POWER
-94.10
Last 100 transactions
Buy: 419 662 \| Sell: 10 978 493

Wolumen Korelacja

Długi: 0.31 (neutral)

Krótki: 0.00 (neutral)

Signal:(55.408) Neutral

Icosavax, Inc. Korelacja

10 Najbardziej pozytywne korelacje
KRTX	0.968
FLXS	0.96
ECHO	0.953
YMAB	0.952
IIN	0.949
MRUS	0.949
LIBY	0.949
HQY	0.948
LCUT	0.948
META	0.947

10 Najbardziej negatywne korelacje
BIOL	-0.97
CYXT	-0.966
PRSO	-0.958
OSTK	-0.957
OMCL	-0.957
RVSB	-0.954
NSTG	-0.953
SOLO	-0.953
SGML	-0.95
ENNV	-0.946

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Icosavax, Inc. Korelacja - Waluta/Towar

0.19
( neutral )

0.56
( weak )

-0.23
( neutral )

-0.49
( neutral )

-0.18
( neutral )

0.88
( strong )

Icosavax, Inc. Finanse

Annual	2022
Przychody:	$582 000
Zysk brutto:	$-1.26M (-216.67 %)
EPS:	$-2.23

FY	2022
Przychody:	$582 000
Zysk brutto:	$-1.26M (-216.67 %)
EPS:	$-2.23

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0

FY	2020
Przychody:	$1.62M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.820

Financial Reports:

No articles found.

Icosavax, Inc.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.